News at GASCO
GASCO Newsletters
GASCO publishes its GASCO Hot Topics Newsletter every other month.
FDA Drug Approvals
See a list of recent GASCO Corporate Member FDA approvals for drugs and new indications.
ASCO & JCO Cancer Portals
Your one-stop resource for the latest disease-specific abstracts, videos, guidelines, and articles.
Winship Community Outreach and Engagement (COE) Community Cancer Mini-Grants
The Winship Cancer Institute of Emory University and its Community Outreach and Engagement (COE) component are pleased to release the Summer 2024 Request for Pilot Grant Proposals for its Community Cancer Mini-Grants pilot project program. The COE's Community Cancer Mini-Grants is a peer-reviewed program that provides pilot funding for projects that implement and evaluate evidence-based interventions to improve community assessment, access, and/or outcomes related to cancer. Winship Cancer Institute of Emory University is Georgia's only National Cancer Institute-designated Comprehensive Cancer Center. This program enables Georgia-based community organizations to obtain funding to implement and evaluate an evidence-based intervention that may focus on cancer prevention, risk reduction, access to screening or treatment, survivorship, or policy that has the potential to impact the community. Winship COE Community Cancer Mini-Grants provide two funding opportunities every year. Successful applications are supported by funds from the Winship's NCI Cancer Center Support Grant (CCSG), with additional support from philanthropy.
Oncology Changes in CPT 2024 Code Set Include Common Treatments, Lab Tests
The CPT 2024 code set contains 230 additions, 49 deletions, and 70 revisions. Oncology changes include chemotherapy code revisions and pathology/lab additions.
Standing in the Gaap
African Americans with multiple myeloma are:
- More likely to be diagnosed.
- Less likely to get treatment.
Multiple myeloma is the most common form of blood cancer in African Americans.
- Multiple myeloma is about 2X more common in African Americans vs White Americans. In fact, 1 in 5 people with multiple myeloma is African American.
- Diagnosing multiple myeloma can be tricky in anyone. But the time it takes to get diagnosed is typically longer for African Americans.
- African Americans are less likely to get certain treatments. However, when receiving the same treatment, African Americans do just as well as and sometimes better than White Americans
Stand Up for Care and Stand in the Gaap with Us
The Standing in the Gaap initiative was created with one goal in mind: to help improve the care of African Americans living with multiple myeloma.
Visit www.StandingInTheGaap.com and and help spread the word.
MyHealthcareFinances
Pfizer has partnered with Triage Cancer to create MyHealthcareFinances.com, a freely available website that helps patients and caregivers understand finances related to healthcare, and steps to take that may help lower their costs.
The goal is to provide an overview of key topics that may be helpful to point individuals in the right direction on where to find more information. By using this tool, it is believed patients can take an important step to help empower their path forward.
MyHealthcareFinances is a collaboration between Pfizer and Triage Cancer, which joins people with a shared passion for improving healthcare-related financial literacy.
